Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$312K Buy
861
+601
+231% +$206K 0.11% 110
2026
Q1
$91.3K Sell
260
-27
-9% -$9.63K 0.04% 212
2025
Q4
$93.8K Buy
287
+1
+0.3% +$317 0.04% 227
2025
Q3
$80.6K Buy
+286
New +$82.9K 0.04% 242

Other funds holding AMGN

Westfuller Advisors's AMGN Position: Q2 2026 in Review

Westfuller Advisors increased its Amgen (AMGN) stake by 231% in Q2 2026, buying an estimated $206K and bringing the position to 861 shares worth $312K. The position accounts for 0.11% of the portfolio, ranked #110.

Westfuller Advisors first reported a position in AMGN in Q3 2025 and has held it in 4 quarters since. 3,149 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Westfuller Advisors held 861 shares of Amgen worth $312K as of Q2 2026.
  • Westfuller Advisors bought 601 Amgen shares in Q2 2026, an estimated $206K.
  • Amgen made up 0.11% of Westfuller Advisors's portfolio in Q2 2026, its #110 holding.
  • Westfuller Advisors first reported a position in Amgen in Q3 2025 and has held it in 4 quarters since.
  • 3,149 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Westfuller Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.